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CLINICAL TOXICOLOGIC STUDIES
ON FREON ® FE 1301

concerned with exposure of human subjects
to varying concentrations with measuremert
of mental alertness and acuity and moni
toring of the electrical activity of the
myocardium. Extensive animal studies had
been conducted by the toxicology group
at the du Pont Company, the Hazelton Lab
oratories and Dr. Back, Wright-Patterson
Air Force Base, Dayton, Ohio.

The Hine Laboratories, Inc.
301 Seventh Street
San Francisco, California 94103
and
Toxicological Group,
Department of Pharmacology,
School of Medicine
University of California at
San Francisco, California 94122 a

Stoppes of the Haskell Laboratories
exposed three volunteers to concentra
tions up to 10% for 3-1/2 minutes. No
other studies had previously been con
ducted on man. The intent of this study
was to obtain data which might help de
fine those levels which could be consid
ered as safe for passengers and operative
personnel in those situations where there
might be need for exposure to FE 1301.

C. H. Hine, M.D., Ph.D.
H. W. Elliott, M.D., Ph.D.
J. W. Kaufman, M.D.
S. Leung, B.A.
a Sponsored jointly by The Boeing Company
and I. E. du Pont de Nemours and Company

Experimental Approach
Material

Summary

The test material FE 1301 is identi
fied chemically as bromotrifluoromethane
(chemical symbol: CBrF3). The material
was furnished through the courtesy of
Freon Products Division of E. I. du Pont
de Nemours and Company. The material was
described as typical of commercial pro
duction and free from impurities. Fluoro
carbon 22B1 (CHBrF2) and fluorocarbon
12B2 (CBr2F2) were stated to be present
at concentrations of less than 1 ppm
though specifications on the product
would allow up to 50 ppm of either com
pound. Free halogen or acids were stated
to be absent.

After conducting appropriate animal
tests to ascertain safe levels, human
subjects were exposed to concentrations
of from 1.25% to 16.9% V/V of FE 1301.
Assessment of judgement, alertness and
neuromuscular skill indicated minimal
but discernible effects at the lowest
concentration in some individuals. At
10% V/V all subjects were effected.
Stage I anesthesia occurred at 15% and
Stage II would probably have occurred at
20%. A marked cardiac arrhythmia re
sulted in one subject exposed to 14%.
There was complete recovery in all sub
jects within 20 minutes after exposure.
No liver dysfunction occurred. The crit
ical level for effective fire control is
near 6%. This level would be acceptable
on clinical toxicologic criteria.

Exposure Facilities
All exposures took place in a cubi
cle exposure chamber of 8064 liter capa
city. The chamber was lighted and equip
ped with circulating fans. All exposures
were made in a static environment. Ex
posure in man lasted up to 25 minutes.

Introduction
This study of the pharmacology and
toxicology of the fluorocarbon fire ex
tinguishing agent, Freon © FE 1301, has
special reference to possible myocardial
sensitizing properties of the compound,
and effects on the central nervous sys
tem.

Determination of FE 1301
An appropriate method was developed
for the determination of air concentra
tions of FE 1301 utilizing an Aerograph
600 gas-liquid chromatograph. For this
purpose we used a hydrogen flame ionization detector and a stainless steel tube
column, i.d. 4 mm. and 15 cm. in length,
packed with 80-100 mesh Polapak "A". A
volume of one ml. of gas under these con
ditions gave a full scale deflection at
16 volumes percent with X4 attenuation.

It was conducted for the purpose of
evaluating the medical aspects of toxicological hazards inherent in the release
of FE 1301 into closed spaces such as
aircraft cockpits or cabins. Although no
adverse effects have been encountered in
the use of portable extinguishers con
taining FE 1301 , it is known that some
halogenated hydrocarbons, as well as
simple hydrocarbons, can cause abnormal
ities in cardiac rhythm when inhaled by
persons with high blood levels of adren
alin.

Production of Desired Concentration
FE 1301 gas was allowed to flow from
the cylinder at a metered rate into the
chamber to give the desired nominal con
centrations. The air and FE 1301 input
were adjusted to achieve the desired con
centration which was then monitored and
maintained at this level (or within 1.4%
of this level) for the remainder of the
exposure.

The investigation was done in two
parts. The first part involved exposure
of dogs to various levels of FE 1301
under fright-producing situations in
order to ascertain whether endogenously
released epinephrine would cause myocar
dial arrhythmias. The second part was
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Final interpretation of the electrocardi
ograms was made without the reader's
knowledge of the concentration to which
the subjects had been exposed.

Exposure of Human Subjects
Test Subjects
Fifteen test subjects were used in
assessment of the effects of FE 1301 on
behavior and 10 on myocardial irritabil
ity. They were drawn from the population
of research personnel, medical and dental
students from the professional schools at
the University of California at San Fran
cisco. The nature of the test and the
risks involved were explained to each sub
ject emphasizing that the clinical pharm
acology of the substance had not been
fully ascertained and that this was part
of the purpose of the experiment.

Results
Characteristics of the Subjects
The age span was 22 to 33 years of
age. Only one of the subjects was re
ceiving chronic medication. Seven had a
past history of allergies and sensitivi
ties. Two of these were currently clini
cally active. One subject had a systolic
murmur accentuated by exercise and had a
history of a congenital heart problem.

General Procedure

Levels of Exposure

Subsequent to acceptance into the
program we questioned them concerning
their previous experience with anesthe
tics, allergies and sensitivities, and
current drug ingestion. A physical ex
amination was performed and their mood
and affect appraised. Where high concen
trations were to be used an electrocardi
ogram was taken. Prior to exposure all
subjects were trained to acceptable Ieve3s
of performance on tests measuring mental
alertness and neuromuscular coordination.
The FE 1301 was administered to four sub
jects at 1.25%, six subjects at 2.5%,
four subjects at 5% and six at 10%. While
in the chamber, subjects made observations
as to sensory stimulation and carried out
tests for mental alertness and neuromus
cular coordination. All exposures were
for 22 minutes or until the subjects com
pleted the schedule given below:

The concentrations determined by GLC
were close to nominal concentrations in
all runs.

Time
(Minutes)

Unusual Events
The experiment proceded satisfactor
ily according to experimental design and
it was not necessary to significantly al
ter any of the procedures during the
course of the investigation. No subject
asked to terminate his chamber exposure;
however, three subjects breathing maskconcentrations of 12% or greater had a
feeling of impending unconsciousness.
Subject 5 developed an unusual myocardial
activity and dissociation of the pace
maker after reaching a level of 16.1%, so
his exposure was discontinued. Return to
normal rhythm occurred within 3 minutes.
It was not necessary to use any resuscitative devices at any time. All subjects
recovered from their central nervous sys
tem depression within 20 minutes after
exposure. Two subjects reported headache
during or following exposure; one of these
persisted for 12 hours.

Test

Record Sensory Experience
0
Record Sensory Experience
1
Record Sensory Experience
2
Record Sensory Experience
5
Perform Romberg
6
Perform Finger-to-Finger
7
Perform Maze
8
Record Sensory Experience
10
Perform Pursuit Rotor
11
Record Sensory Experience
15
Perform Simple Reaction
16
Record Sensory Experience
20
Perform Maze
21
Leave chamber and narrate description
of exposure experience.

Mental Alertness and Neuromuscular Coor
dination
There was a deterioration in perfor
mance in one or more tests at all of the
four levels of exposure. Test in which
the fingers were brought into proximation
was the most sensitive and showed de
creased performance at the lowest level
tested. The maze test was second in sen
sitivity and decreased performance and
was correlated with increasing FE 1301
concentration. The Romberg test was the
least sensitive showing no effect until
the 10% level was reached when 3 of 6 sub
jects failed the test. Scores obtained
in the rotor and simple reaction time
tests did not correlate with concentration;
in a number of instances in both tests
there was improvement following exposure.
At the 1.25% concentration there was con
vincing evidence of decrement in the
finger-to-finger test and decrement in 4
of the 8 maze tests. At 2.5% finger-tofinger test again was more poorly per
formed by all subjects and there was a de
crease in coordination as measured by the
rotor test. There was no significant
change at the 5% level of exposure. At

Experiments Monitoring Vital Signs
Ten subjects were administered FE
1301 in concentrations of 5-16% by mask.
During this time pulse, respirations,
blood pressure and electrical activity -of
the heart were monitored. Carbon dioxide
at 5-10% was administered intermittently
to six subjects.
Control of Bias
The experiment was carried out on a
single blind basis but without placebo
control, subjects being unaware of the
concentrations that were being administered.
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beginning inebriation at the 10% level.
A feeling of pending unconsciousness was
related by three subjects at concentra
tions of 14.4 to 16.9%. Only one subject
who reached 15% did not feel markedly
confused.

the 10% level there was a marked decre
ment in performance of the maze test as
well as the finger-to-finger coordination
Im
test and failure of Romberg test.
provement in skill test scores when the
is exposed to central nervous system de
pressants is not the expected event but
is sometimes observed in tests of the
type used here. Two explanations are 1)
an increase in the learning curve which
continues during the testing session and
2) relaxation of tensions with a decrease
in tendency to over-correct. At the 10%
level there were 6 tests in which there
were improvements , 7 in which there was
no change and 23 in which there was a de
crement performance.

Electrocardiographic Changes
There were no significant and unex
pected findings at the baseline electro
cardiograms. No changes occurred in
seven of the EKG's during exposure even
when concentrations of as high as 16.9%
were reached. One subject had lowering
of the T-wave 5 minutes after exposure to
8.2% of FE 1301 and 26 minutes later at a
concentration of 12.1% when carbon dioxide
had been added to the inhalant mixture.
A second subject had flattening of the Twaves after 10 minutes of exposure at
12.5% FE 1301 >and increased sinus arrhy
thmia at a later time. The most marked
changes were noted in a 24-year old, 165
pound, Caucasian male of athletic build,
hypertonic in mood and affect. Five min
utes after exposure to 12.8% of FE 1301,
he developed a flattening of the T-wave.
This was followed in two minutes by pre
mature ventricular contractions and one
minute later when the concentration had
reached 14% by auricular-ventricular dis
sociation. Rhythm was restored two min
utes after cessation of the exposure.

Descriptive Words
The results of this test indicated
a clear pattern of change in self apprai
sal of mood and mental clarity. There
was a decrease in words with positive
values such as alert, careful, clear
headed, forceful, industrious, resource
ful and increase in words with negative
values such as detached, drowsy, dull,
elated, groggy, irritable, lackadaisical,
lightheaded, sluggish and talkative.
Fifty percent of the subjects at the low
est level and all of the subjects at the
highest.level indicated a feeling of
lightheadedness . This generally was
noted after 3 to 5 minutes of exposure.

Discussion

Sensory Appraisal

Study of the toxicity and biology of
the fluorocarbons indicates that FE 1301
is one of the least toxic members of this
class. The majority of overt pharmacologic signs refer to the central nervous
system, the principal effect being narco
sis, and anesthesia. However, there have
been reported tremors and convulsive re
actions in dogs exposed at high concen
trations. Based on our experiments the
only effect on the central nervous system
of man which would be expected at concen
trations short of those producing uncon
sciousness would be decreased awareness
and alertness and slight confusion. A
large number of halogenated hydrocarbons
may cause cardiac sensitization to epinephrine; according to the evidence devel
oped in animals and now in man FE 1301
would have to be classified among these
compounds. The occurrence of cardiac ar
rhythmias is dose related, based on exten
sive experience with the anesthetics cy
clopropane and chloroform. Arrhythmias
produced by these compounds and presumably
FE 1301 include a wandering pacemaker,
atrial extrasystoles, atrial fibrillations,
sporadic ventricular extrasystoles, mild
focal and multifocal ventricular tachy
cardias and bigeminal rhythm. Given a
large enough series of exposed persons at
high enough concentrations and under se
vere conditions of epinephrine release,
the probability exists that FE 1301 could
produce myocardial sensitization and sig
nificant cardiac arrhythmia. The question
therefore evolves about the relative de
gree of risk. The number of subjects in
our study in whom the electrical activity
was monitored is small, however we observed

The majority of subjects did not ex
perience eye irritation, nose irritation
or pulmonary discomfort during most of
the period of testing. No eye irritation
was noted at the two lower levels. Two
subjects noted a slight irritation at
both the 5 and 10% levels while one re
sponded with moderate irritation at the
10% level. Only slight nasal irritation
was noted by any subjects at the three
lower levels; however, one subject classi
fied nasal irritation at the 10% level as
severe. This was identified as a brominelike odor. Pulmonary discomfort descri
bed as either a feeling of coolness in
the respiratory tract or nasal stuffiness
was rated as no more than slight at any
level. Olefactory recognition was rated
as moderate in intensity by one or more
subjects at all levels. Generally there
was a decreased olefactory cognition with
time. Lightheadedness just detected at
the lower levels of exposure increased to
a moderate disturbance in alertness and
mental acuity in one of the four subjects
at the 5% level, while three of the six
subjects at the 10% level described
marked sensation of giddiness and loss of
normal alertness. Judging from all fac
tors, it can be concluded that at concen
trations at 10% a state of inebriation
was beginning to appear.
The narrative descriptions defined
varying degrees of central nervous system
depression with paresthesias, alteration
in auditory perception, euphoria, and
silliness occurring at levels of 5%.
There was numbness about the lips and
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no arrhythmias at concentrations below
10%. We did not establish an anesthetic
level for our human subjects. However,
the majority approached Stage I (anal
gesia) at concentrations of about 14%.
The stage of delerium would probably have
been achieved when an additional 2-3% was
present. Loss of consciousness would oc
cur, in our opinion, in most people at
about 20 volumes %. At concentrations of
10% of FE 1301 or greater all subjects ex
perienced some degree of confusion, mis
interpretation of the surroundings or un
steadiness and giddiness. Clearly, one
would have difficulty in sustaining com
plex operations at such concentrations.
Tasks requiring precise timing and high
degree of coordination would undoubtedly
deteriorate. At the 5% level while ef
fected to some degree by lightheadedness
and change in mood, skilled tasks could
be performed and even balance and locomo
tion were unimpaired. In the sitting po
sition the sensation was not at all un
pleasant nor was there any distress. In
halation of the FE 1301 produces a sen
sation which in the inexperienced is
slightly disturbing; however, those who
previously had received anesthetics or
consumed moderate quantities of alcoholic
beverages were familiar with the sensa
tion produced and were not disturbed by
the exposure at concentrations of 10% or
below.
There is no reason, based on our
study, to believe that passengers would
have any significant degree of confusion
or be incapable of leaving their seats
were rapid evacuation of the cabin area
necessary at a FE 1301 level of 6%.
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